Another study indicated that METTL3-mediated m6A methylation decreased the expression of lncRNA DBH-AS1 in pancreatic cancer, while DBH-AS1 increased the sensitivity of pancreatic cancer cells to gemcitabine through the miR-3163/USP44 axis. This evidence concerns the gene METTL3 and pancreatic neoplasm.